Find clinical trials for Triple Negative Breast Cancer in Barcelona, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Barcelona, CT, ESP:
Triple negative breast cancer (TNBC) represents approximately 15% of all breast cancers (BC) wo ...
Phase 1, Phase 2
Barcelona, Cataluña, Spain and 22 other locations
Triple-negative breast cancer (TNBC) is a group of tumors that occurs mainly in young, premenopausal wom ...
Phase 2
Barcelona, Spain and 43 other locations
This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast...
Phase 3
Barcelona, Spain and 197 other locations
and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen rec...
Phase 2, Phase 3
Barcelona, Catalunya [Cataluña], Spain and 288 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Barcelona, Spain and 283 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...
Phase 3
Barcelona, Spain and 374 other locations
after induction with first-line chemotherapy plus pembrolizumab in triple negative breast cancer (TNBC). The prim...
Phase 2
Barcelona, Spain and 121 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...
Phase 3
Barcelona, Spain and 506 other locations
, and anti-tumor activity of each regimen at the MTD/RD....
Phase 1
Barcelona, Catalonia, Spain and 8 other locations
This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...
Phase 3
Barcelona, Spain and 227 other locations
Clinical trials
Research sites
Resources
Legal